Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Midcap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹190.42 |
| 26 Aug 2009 | ₹101.13 |
| 08 May 2011 | ₹113.49 |
| 17 Jan 2013 | ₹142.17 |
| 30 Sep 2014 | ₹245.58 |
| 11 Jun 2016 | ₹332.23 |
| 21 Feb 2018 | ₹411.16 |
| 04 Nov 2019 | ₹365.18 |
| 16 Jul 2021 | ₹643.37 |
| 28 Mar 2023 | ₹717.52 |
| 08 Dec 2024 | ₹1225.99 |
| 20 Aug 2026 | ₹1251.79 |
| Metric | SBI · Regular NAV ₹243.10 Very High risk ★★☆☆☆ | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| +5.43% | +8.71% | |
| +12.80% | +18.06% | |
| +14.71% | +16.16% | |
| +13.40% | +15.69% | |
| +13.20% | +16.93% | |
| +11.86% | — | |
| +15.74% | +19.07% | |
| +15.91% | +16.56% | |
| +15.95% | +16.43% | |
| Risk | ||
| 13.38% | 16.23% | |
| 0.47 | 0.74 | |
| 0.63 | 1.00 | |
| -78.65% | -37.39% | |
| Nifty Midcap 150 | — | |
| -3.63% | +0.94% | |
| 0.85 | 0.94 | |
| 76.8% | 96.2% | |
| 85.4% | 90.1% | |
| 1.80% | 2.04% | |
| ₹22,745Cr | ₹7,594Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 33% | 41% | |
| Pradeep Kesavan · 2.7y | — | |
| 03 Apr 2006 | — | |
| 55 | — | |
| 27.5% | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.